science pharmaceutical expo biotech jobs
Originally published online as doi:10.1189/jlb.0203062 on September 2, 2003

Published online before print September 2, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0203062v1
74/6/1064    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frleta, D.
Right arrow Articles by Wade, W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frleta, D.
Right arrow Articles by Wade, W. F.
(Journal of Leukocyte Biology. 2003;74:1064-1073.)
© 2003 by Society for Leukocyte Biology

CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells

Davor Frleta, Randolph J. Noelle and William F. Wade1

Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, New Hampshire

1 Correspondence: Department of Microbiology and Immunology, 630W Borwell Building, Dartmouth Medical School, 1 Medical Center Drive, Lebanon, NH 03756. E-mail: William.F.Wade{at}Dartmouth.Edu

Toll-like receptors (TLRs) recognize pathogen-associated molecular patterns, which are non-self macromolecular components of pathogens that allow the innate-immune system to recognize infection. TLRs are expressed on macrophages and dendritic cells (DC). TLR stimulation or CD40 agonists can induce inflammatory cytokine secretion from macrophages and DC, and promote DC maturation. The regulation of TLR expression by inflammation has begun to be explored. Our studies have focused on the regulation of TLR4 surface expression on DC. TLR4, along with the adaptor molecule MD2, is involved in the recognition of lipopolysaccharide (LPS). CD40 stimulation via cross-linked anti-CD40 monoclonal antibody (mAb) up-regulates TLR4-MD2 surface expression on a DC cell line (DC2.4) and on ex vivo-cultured splenic DC. LPS treatment down-regulated surface TLR4-MD2 on DC2.4 cells, but if combined with anti-CD40 mAb, increased TLR4-MD2 expression was observed. The increased TLR4-MD2 surface expression by any treatment did not correlate with TLR4 mRNA levels. The functional consequence of increased TLR4-MD2 expression following LPS and anti-CD40 treatment was examined. Although CD40 prestimulation did slightly enhance interleukin-12p70 secretion after LPS restimulation, simultaneous anti-CD40 mAb and LPS treatment, which up-regulates TLR4-MD2 complex, does not restore DC responsiveness to subsequent LPS.

Key Words: lipopolysaccharide • CD40 • toll-like receptors




This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
T. Kawasaki, M. A. Choudhry, M. G. Schwacha, S. Fujimi, J. A. Lederer, K. I. Bland, and I. H. Chaudry
Trauma-hemorrhage inhibits splenic dendritic cell proinflammatory cytokine production via a mitogen-activated protein kinase process
Am J Physiol Cell Physiol, March 1, 2008; 294(3): C754 - C764.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. M Gorczynski, Y. Kai, and K. Miyake
MD1 Expression Regulates Development of Regulatory T Cells
J. Immunol., July 15, 2006; 177(2): 1078 - 1084.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. A. Greene, J. L. DeVecchio, M. P. Gould, J. J. Auletta, and F. P. Heinzel
In vivo and In vitro Regulation of Type I IFN Synthesis by Synergistic Effects of CD40 and Type II IFN
J. Immunol., May 15, 2006; 176(10): 5995 - 6003.
[Abstract] [Full Text] [PDF]